Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scapa ready to launch £33 million growth programme:

This article was originally published in Clinica

Executive Summary

Medical tape company Scapa UK is preparing to launch a £33m ($49m) capital investment programme, after being awarded two regional selective assistance grants totalling £4m. The six-year programme is aimed at consolidating production, growth, R&D and training at its Ashton-under-Lyne (Manchester) and Dunstable plants. The Blackburn, Lancashire company manufactures its foam-based medical and technical adhesive tapes at five sites; it also produces special compounds and cables. The two grants awarded by the Department of Trade and Industry are offered on a phased basis to support the programme.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel